$Cassava Sciences (SAVA.US)$ New Bullish SAVA August 2024 de...
$Cassava Sciences (SAVA.US)$ New Bullish SAVA August 2024 deck " Intellectual Property – As of February 2024
• Simufilam is a novel molecule. Cassava Sciences owns exclusive, worldwide rights to
simufilam and related technologies, without financial obligations to any third party.
• Composition of matter patent protection for simufilam and other novel filamin-binding
molecules includes nine issued U.S. patents.
• Issued U.S. patents currently run through 2039.
• In the U.S., we believe SavaDx may be protected by trade secrets, know-how and other
proprietary rights technology."
• Simufilam is a novel molecule. Cassava Sciences owns exclusive, worldwide rights to
simufilam and related technologies, without financial obligations to any third party.
• Composition of matter patent protection for simufilam and other novel filamin-binding
molecules includes nine issued U.S. patents.
• Issued U.S. patents currently run through 2039.
• In the U.S., we believe SavaDx may be protected by trade secrets, know-how and other
proprietary rights technology."
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
